CAS RN: 60676-51-9
Methyl (Z)-2-Acetamido-3-phenylacrylate
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
≥95% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20251019
250mg / 1g / 5g
Confirm by inquiry
Shanghai 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 60676-51-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Hong Kong
Inquiry
60676-51-9 / methyl 2-acetamido-3-phenylprop-2-enoate
Standard CAS: 60676-51-9
Multi CAS: Yes
Basic Information
copy
CAS
60676-51-9 copy
Multi CAS
Yes copy
Molecular Formula
C12H13NO3 copy
Molecular Weight
219.240000 copy
Exact Mass
219.089543 copy
InChI
InChI=1S/C12H13NO3/c1-9(14)13-11(12(15)16-2)8-10-6-4-3-5-7-10/h3-8H,1-2H3,(H,13,14) copy
InChIKey
USKHBABPFFAKJD-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
16 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.17 copy
Rotatable bonds
3 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
60.25 copy
TPSA
55.4 copy
LogP / Solubility
WLOGP
1.34 copy
MLOGP
1.18 copy
XLogP3
1.6 copy
Consensus LogP
1.37 copy
Log S (ESOL)
-2.12 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.32 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.55 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.11 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy